Document is current
Any future updates will be listed below
-
Authors
Marschollek, Karol
Martynowicz, Helena
Budrewicz, Sławomir
Straburzyński, Marcin
Waliszewska-Prosół, Marta
-
Funding
Funding for this research was provided by:
The study was funded from ‘the Initiative of Excellence – Research University’ provided by Wroclaw Medical University, Wroclaw, Poland (task number: IDUB.C230.24.001)
- License Information
-
More Information
Article History
Received: 9 May 2026
Accepted: 8 June 2026
First Online: 19 June 2026
Declarations
:
: The study was approved by the Ethics Committee at Wrocław Medical University (No. KB/39/2025). The study was conducted according to the principles set out in the Declaration of Helsinki. All data was kept confidential and in accordance with data protection regulations, while the anonymity of respondents was maintained.
: Karol Marschollek has received honoraria from AbbVie for speaker activities.Sławomir Budrewicz and Helena Martynowicz declare no competing interests related to the present study.Marcin Straburzyński - reports personal fees from AbbVie, Pfizer and Teva for speaker activities. Marta Waliszewska-Prosół is a member of the Editorial Board for The Journal of Headache and Pain and reports personal fees from AbbVie, Pfizer, and Teva for speaker activities. The authors declare no other relevant affiliations or financial interests with any organization or entity that has a financial interest in or conflict with the subject matter or materials discussed in this manuscript, apart from those disclosed.
